Related Experiment Video
Updated: Apr 16, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Probiotics Reduce Necrotizing Enterocolitis Severity in HIV-exposed Premature Infants
Evette Van Niekerk1, Daniel G Nel2, Reneé Blaauw3
1Division Human Nutrition, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa evettev@sun.ac.za.
Insights
Probiotic supplementation reduced necrotizing enterocolitis (NEC) in premature infants. While not reducing NEC incidence in HIV-exposed infants, probiotics lessened disease severity in this group.
Area of Science:
- Neonatal Medicine
- Microbiology
- Infectious Diseases
Background:
- Necrotizing enterocolitis (NEC) is a serious condition in premature infants.
- Human immunodeficiency virus (HIV) exposure may influence NEC risk.
- Probiotics are explored for preventing neonatal complications.
Purpose of the Study:
- To evaluate the impact of probiotics on NEC incidence in premature infants.
- To compare outcomes between HIV-exposed and HIV-unexposed infants.
Main Methods:
- Randomized controlled trial involving HIV-exposed and HIV-unexposed premature infants.
- Intervention group received Lactobacillus rhamnosus GG and Bifidobacterium infantis.
- Control group received a placebo.
Main Results:
- Overall NEC incidence was significantly lower in the probiotic group (3%) compared to placebo (6%).
- No significant difference in NEC incidence or death was observed between HIV-exposed and HIV-unexposed infants.
- A significant reduction in NEC severity was noted in HIV-exposed infants receiving probiotics.
Conclusions:
- Probiotic supplementation effectively reduces NEC incidence in premature infants.
- Probiotics did not lower NEC incidence in HIV-exposed premature infants but did reduce disease severity.
- Further research is needed on probiotics in high-risk neonatal populations.
Objective:
To assess the effect of probiotics on the incidence of necrotizing enterocolitis (NEC) in premature infants born to human immunodeficiency virus (HIV)-positive and HIV-negative women.
Patients And Methods:
HIV-exposed and HIV-unexposed premature infants were randomized to either the probiotic or the placebo group. The probiotic consisted of 1 × 10(9) colony-forming units, Lactobacillus rhamnosus GG and Bifidobacterium infantis per day.
Results:
In total, 74 HIV-exposed and 110 HIV-unexposed infants were enrolled and randomized. The incidence of death [4 (5.4%) vs. 7 (6%); p = 0.79] and NEC [4 (5%) vs. 5 (5%); p = 0.76] did not differ significantly between the HIV-exposed and HIV-unexposed groups. A significant difference was found for total NEC incidence between the study and control groups [3 (3%) vs. 6 (6%); p = 0.029]. The incidence of NEC in the HIV-exposed group differed significantly [Bells I 2 (5%) vs. Bells III 2 (5%); p = 0.045).
Conclusion:
Probiotic supplementation reduced the incidence of NEC in the premature very low birth weight infants; however, results failed to show a lower incidence of NEC in HIV-exposed premature infants. A reduction in the severity of disease was found in the HIV-exposed study group.
More Related Videos
Related Concept Videos
Probiotics
Development of Human Microbiota
Development of the Oral Microbiota
Microbiota of the Stomach and Small Intestine
Introduction to the Human Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...

